Synergy between methionine stress and chemotherapy in the treatment of brain tumor xenografts in athymic mice

Cancer Research

Volumn 61, Issue 10, 2001, Pages 4017-4023

  Kokkinakis, Demetrius M ^a   Hoffman, Robert M ^c   Frenkel, Eugene P ^a   Wick, Jacquelynn B ^a   Han, Qinghong ^c   Xu, Mingxu ^c   Tan, Yuying ^c   Schold, S Clifford ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c ANTICANCER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; METHIONINE; RECOMBINANT METHIONINE GAMMA LYASE; TEMOZOLOMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN TUMOR; CONTROLLED STUDY; DIET RESTRICTION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; GENOTOXICITY; MOUSE; NONHUMAN; NUDE MOUSE; NUTRITIONAL STATUS; PRIORITY JOURNAL;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CARBON-SULFUR LYASES; CARMUSTINE; CHOLINE; DACARBAZINE; DIET; DOWN-REGULATION; DRUG SYNERGISM; GLIOBLASTOMA; HUMANS; METHIONINE; MICE; MICE, INBRED BALB C; MICE, NUDE; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; RECOMBINANT PROTEINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0035872410     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. New treatment strategies for malignant gliomas
2. Isolation and characterization of human malignant glioma cells from histologically normal brain
3. Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine chemotherapy for the treatment of anaplastic gliomas
4. Retrospective study of the correlation between DNA repair protein alky transferase and survival of brain tumor patients treated with carmustine
5. 6-methylguanine-DNA methyltransferase levels with survival of malignant astrocytoma patients treated with bis-chloroethylnitrosourea: A Southwest Oncology Group study
6. 6-alkylguanine-DNA alkyltransferase
7. Multicenter Phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse
8. Multicentre CRC Phase II trial of temozolomide in recurrent or progressive high-grade glioma
9. 6-Methylguanine-DNA methyltransferase in normal and malignant tissue of the breast
10. 6-methylguanine-DNA methyltransferase in the resistance of pancreatic tumors to DNA alkylating agents
11. 3 of deoxycytidine on opposite strands of duplex DNA
12. Genomic instability and tolerance to alkylating agents
13. Self-destruction and tolerance in resistance of mammalian cells to alkylation damage
14. Involvement of the DNA mismatch repair system in antineoplastic drug resistance
15. 6-Benzylguanine and its role in chemotherapy
16. Anti-neoplastic activity of sequenced administration O6-benzylguanine, streptozotocin and 1.3-bis(2-chloroethyl)-1-nitrosourea in vitro and in vivo
17. 6-(4-Bromothenyl)guanine improves the therapeutic index of temozolomide against A375M melanoma xenografts
18. 6-benzyl-2′-deoxyguanosine and BCNU
19. 6-benzylguanine enables the specific therapy of nitrosourea-resistant intracranial human glioma xenografts in athymic rats with 1,3-bis(2-chloroethyl)-1-nitrosourea
20. 6-benzyl-2′-deoxyguanosine and 1,3-bis(2-chloroethyl)-1-nitrosourea
21. Temozolomide and treatment of malignant glioma
22. 6-methylguanine-DNA methyltransferase analysis and response to Temodal in newly diagnosed malignant glioma
23. 6-benzylguanine for patients undergoing surgery for malignant gliomas
24. 6-Benzylguanine potentiates the in vivo toxicity and clastogenicity of temozolomide and BCNU in mouse bone marrow
25. 6-methylguanine-DNA methyltransferase increases azoxymethane-induced colonic tumors in rats
26. Regulation of O6-methylguanine-DNA methyltransferase by methionine in human tumour cells
27. Effect of long-term depletion of plasma methionine on the growth and survival of human brain tumor xenografts in athymic mice
28. The preparation of endotoxin-free L-methionine-alpha-deamino-gamma-mercaptomethane-lyase (L-methioninase) from Pseudomonas putida
29. Overexpression and large-scale production of recombinant L-methionine-alpha-deamino-gamma-mercaptomethane-lyase for novel anticancer therapy
30. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
31. 6-alkylguanine-DNA alkyltransferase which confer significant resistance of human glial tumor xenografts to treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea and temozolomide
32. Enhanced in vitro selective toxicity of chemotherapeutic agents for human cancer cells based on a metabolic defect
33. Reversible growth arrest in simian virus 40-transformed human fibroblasts
34. Decreased rat rhabdomyosarcoma pulmonary metastases in response to a low methionine diet
35. Therapeutic tumor-specific cell-cycle block induced by methionine starvation in vivo
36. Anticancer efficacy of methioninase in vivo
37. Human tumors are methionine dependent in vivo
38. Synergistic effect of methionine-depleting total parenteral nutrition with 5-fluorouracil on human gastric cancer: A randomized, prospective clinical trial
39. Evaluation of the survival time of A0-90 clinical trial for progressive or recurrent gastric cancer
40. Antitumor effect of methionine-depleting total parenteral nutrition with doxorubicin administration on Yoshida sarcoma-bearing rats
41. Anticancer efficacy in vivo and in vitro, synergy with 5-fluorouracil, and safety of recombinant methioninase
42. Efficacy of recombinant methioninase in combination with cisplatinum on human colon tumors in nude mice
43. The metabolic defect of methionine dependence occurs frequently in human tumor cell lines
44. Serum methionine depletion without side effects by methioninase in metastatic breast cancer patients
45. Recombinant methioninase infusion reduces the biochemical endpoint of serum methionine with minimal toxicity in high-stage cancer patients